UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?

Movement disorders, 2019-10, Vol.34 (10), p.1406-1422

2019

Volltextzugriff (PDF)

Sensitivity and specificity of phospho‐Ser129 α‐synuclein monoclonal antibodies

Journal of comparative neurology (1911), 2018-08, Vol.526 (12), p.1978-1990

2018

Volltextzugriff (PDF)

Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents

Journal of comparative neurology (1911), 2014-08, Vol.522 (11), p.2465-2480

2014

Volltextzugriff (PDF)

Initiation and propagation of α-synuclein aggregation in the nervous system

Molecular neurodegeneration, 2020-03, Vol.15 (1), p.19-19, Article 19

2020

Volltextzugriff (PDF)

Effects of α-synuclein on axonal transport

Neurobiology of disease, 2017-09, Vol.105, p.321-327

Volpicelli-Daley, Laura A

2017

Volltextzugriff (PDF)

microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease

The Journal of neuroscience, 2016-02, Vol.36 (8), p.2383-2390

2016

Volltextzugriff (PDF)

α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration

Neurobiology of disease, 2017-09, Vol.105, p.84-98

2017

Volltextzugriff (PDF)

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

Neuron (Cambridge, Mass.), 2011-10, Vol.72 (1), p.57-71

2011

Volltextzugriff (PDF)

How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?

Journal of neurochemistry, 2016-10, Vol.139 (S1), p.131-155

2016

Volltextzugriff (PDF)

Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats

Proceedings of the National Academy of Sciences - PNAS, 2014-06, Vol.111 (25), p.9289-9294

2014

Volltextzugriff (PDF)

LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model

Molecular therapy. Nucleic acids, 2017-09, Vol.8, p.508-519

2017

Volltextzugriff (PDF)

Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions

Neurobiology of disease, 2020-02, Vol.134, p.104708-104708, Article 104708

2020

Volltextzugriff (PDF)

Pα-syn mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria

Neurobiology of disease, 2019-04, Vol.124, p.248-262

2019

Volltextzugriff (PDF)

Trophic factors for Parkinson's disease: To live or let die

Movement disorders, 2015-11, Vol.30 (13), p.1715-1724

2015

Volltextzugriff (PDF)

Excitatory synaptic structural abnormalities produced by templated aggregation of α-syn in the basolateral amygdala

Neurobiology of disease, 2024-09, Vol.199, p.106595, Article 106595

2024

Volltextzugriff (PDF)

Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain

Molecular neurodegeneration, 2022-01, Vol.17 (1), p.7-7, Article 7

2022

Volltextzugriff (PDF)

Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson's Disease

Frontiers in cellular neuroscience, 2021-03, Vol.15, p.626128-626128

2021

Volltextzugriff (PDF)

Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy

Neurobiology of disease, 2023-10, Vol.187, p.106287-106287, Article 106287

2023

Volltextzugriff (PDF)

Corrigendum to “α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration” [Neurobiol. Dis., Volume 105 (2017) Article 84, 98]

Neurobiology of disease, 2021-11, Vol.159, p.105506-105506, Article 105506

2021

Volltextzugriff (PDF)

α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons

Acta neuropathologica communications, 2018-05, Vol.6 (1), p.35-35, Article 35

2018

Volltextzugriff (PDF)

Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates

Nature protocols, 2014-09, Vol.9 (9), p.2135-2146

2014

Volltextzugriff (PDF)

Isoform-selective effects of the depletion of ADP-ribosylation factors 1-5 on membrane traffic

Molecular biology of the cell, 2005-10, Vol.16 (10), p.4495-4508

2005

Volltextzugriff (PDF)

Invisible Killers

Movement disorders, 2016-01, Vol.31 (1), p.44-44

2016

Volltextzugriff (PDF)

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein

Acta neuropathologica communications, 2021-11, Vol.9 (1), p.180-180, Article 180

2021

Volltextzugriff (PDF)

Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain

Acta neuropathologica communications, 2023-12, Vol.11 (1), p.201-21, Article 201

2023

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(87)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?

Sensitivity and specificity of phospho‐Ser129 α‐synuclein monoclonal antibodies

Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents

Initiation and propagation of α-synuclein aggregation in the nervous system

Effects of α-synuclein on axonal transport

microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease

α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?

Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats

LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model

Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions

Pα-syn mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria

Trophic factors for Parkinson's disease: To live or let die

Excitatory synaptic structural abnormalities produced by templated aggregation of α-syn in the basolateral amygdala

Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain

Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson's Disease

Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy

Corrigendum to “α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration” [Neurobiol. Dis., Volume 105 (2017) Article 84, 98]

α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons

Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates

Isoform-selective effects of the depletion of ADP-ribosylation factors 1-5 on membrane traffic

Invisible Killers

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein

Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain

Suchergebnisse filtern